Pharmosa Biopharm Inc. (TPEX:6875)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
41.80
-0.45 (-1.07%)
Feb 11, 2026, 1:30 PM CST
Market Cap5.45B -18.8%
Revenue (ttm)136.72M +170.6%
Net Income-237.74M
EPS-1.85
Shares Out129.09M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume122,361
Average Volume237,161
Open42.25
Previous Close42.25
Day's Range41.40 - 42.50
52-Week Range37.00 - 65.00
Beta0.33
RSI24.55
Earnings DateMar 6, 2026

About Pharmosa Biopharm

Pharmosa Biopharm Inc., a biotechnology company, focuses on developing drugs in Taiwan. It develops L606, an inhalation/device combination for the treatment of pulmonary arterial hypertension and pulmonary hypertension associated with interstitial lung disease; and L608, an inhalation/device combination for the treatment of pulmonary vascular disease. The company was formerly known as Pharmosa Limited and changed its name to Pharmosa Biopharm Inc. in October 2016. Pharmosa Biopharm Inc. was founded in 2000 and is headquartered in Taipei, Taiwan... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2000
Employees 40
Stock Exchange Taipei Exchange
Ticker Symbol 6875
Full Company Profile

Financial Performance

Financial Statements